日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The mTOR inhibitor everolimus in combination with azacitidine in patients with relapsed/refractory acute myeloid leukemia: a phase Ib/II study

mTOR抑制剂依维莫司联合阿扎胞苷治疗复发/难治性急性髓系白血病患者:一项Ib/II期研究

Tan, Peter; Tiong, Ing Soo; Fleming, Shaun; Pomilio, Giovanna; Cummings, Nik; Droogleever, Mark; McManus, Julie; Schwarer, Anthony; Catalano, John; Patil, Sushrut; Avery, Sharon; Spencer, Andrew; Wei, Andrew

Efficacy of an Fc-modified anti-CD123 antibody (CSL362) combined with chemotherapy in xenograft models of acute myelogenous leukemia in immunodeficient mice

在免疫缺陷小鼠急性髓系白血病异种移植模型中,Fc修饰的抗CD123抗体(CSL362)联合化疗的疗效

Lee, Erwin M; Yee, Dean; Busfield, Samantha J; McManus, Julie F; Cummings, Nik; Vairo, Gino; Wei, Andrew; Ramshaw, Hayley S; Powell, Jason A; Lopez, Angel F; Lewis, Ian D; McCall, Martin N; Lock, Richard B

Plasma levels of soluble interleukin 1 receptor accessory protein are reduced in obesity.

肥胖症患者血浆中可溶性白细胞介素 1 受体辅助蛋白的水平降低

Bozaoglu Kiymet, Attard Chantal, Kulkarni Hemant, Cummings Nik, Diego Vincent P, Carless Melanie A, Shields Katherine A, Johnson Matthew P, Kowlessur Sudhir, Dyer Thomas D, Comuzzie Anthony G, Almasy Laura, Zimmet Paul, Moses Eric K, Göring Harald H H, Curran Joanne E, Blangero John, Jowett Jeremy B M

Genome-wide scan identifies a quantitative trait locus at 4p15.3 for serum urate

全基因组扫描在4p15.3处鉴定出一个与血清尿酸相关的数量性状基因座。

Cummings, Nik; Dyer, Thomas D; Kotea, Navaratnam; Kowlessur, Sudhir; Chitson, Pierrot; Zimmet, Paul; Blangero, John; Jowett, Jeremy B M

Chemerin is associated with metabolic syndrome phenotypes in a Mexican-American population.

在墨西哥裔美国人群中,趋化因子与代谢综合征表型相关

Bozaoglu Kiymet, Segal David, Shields Katherine A, Cummings Nik, Curran Joanne E, Comuzzie Anthony G, Mahaney Michael C, Rainwater David L, VandeBerg John L, MacCluer Jean W, Collier Greg, Blangero John, Walder Ken, Jowett Jeremy B M